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Introduction
Trichomonas vaginalis is known to be an important
pathogen causing the most prevalent non-viral sexually
transmitted disease worldwide and has been used for the
study of host-parasite co-rrelationship [1]. Host immunogens
and protozoan factors cause a distinct interaction during
T. vaginalis infection in the vaginal tract. There are a few
studies about the host-parasite co-rrelationship, especially
trophozoites of T. vaginalis interacting with mucin [2], and
then contact with vaginal epithelial cells (VECs) at iron-
regulated surface proteins of T. vaginalis [3]. Adherence of
the host epithelium by T. vaginalis also occurs via a specific
interaction with the extracellular matrix basement membrane
glycoproteins [4].
In the pathogenesis of T. vaginalis, iron is one of the
virulence factors that modulates diverse aspects of
T. vaginalis, including cytoadherence, metabolic activity,
and resistance to complement lysis [5, 6]. T. vaginalis has
ways of acquiring iron from lactoferrin [3]. T. vaginalis
takes up lactoferrin via specific receptors, which trigger
iron accumulation and activity of pyruvate ferridoxin
oxidoreductase [7]. Iron availability from lactoferrin caused
enhanced binding to the host epithelial cells by increased
amount of adhesins [8]. T. vaginalis also interacts with
erythrocytes, which provide both lipid and iron for the
parasite [9], and the action of two adhesion proteins, AP51
and AP65, triggers iron acquisition from hemoglobin by
T. vaginalis [10]. Cultivation of T. vaginalis in iron-depleted
medium shows no pathology, but could cause subcutaneous
abscesses in mice [11].
Adhesion of fluorescence-labeled T. vaginalis to various
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Trichomonas vaginalis is a pathogen that triggers severe immune responses in hosts. T. vaginalis
α-actinin 2 (Tvα-actinin 2) has been used to diagnose trichomoniasis. Tvα-actinin 2 was
dissected into three parts; the N-terminal, central, and C-terminal portions of the protein (#1,
#2, and #3, respectively). Western blot of these Tvα-actinin 2 proteins with pooled patients’
sera indicated that #2 and #3, but not #1, reacted with those sera. Immunofluorescence assays
of two different forms of T. vaginalis (trophozoites and amoeboid forms), using anti-Tvα-
actinin 2 antibodies, showed localization of Tvα-actinin 2 close to the plasma membranes of
the amoeboid form. Fractionation experiments indicated the presence of Tvα-actinin 2 in
cytoplasmic, membrane, and secreted proteins of T. vaginalis. Binding of fluorescence-labeled
Trichomonas to vaginal epithelial cells and prostate cells was decreased in the antibody blocking
experiment using anti-Tvα-actinin 2 antibodies. Pretreatment of T. vaginalis with anti-rTvα-
actinin 2 antibodies also resulted in reduction in its cytotoxicity. Flow cytometry, ligand-
binding immunoblotting assay, and observation by fluorescence microscopy were used to
detect the binding of recombinant Tvα-actinin 2 to human epithelial cell lines. Specifically, the
truncated N-terminal portion of Tvα-actinin 2, Tvα-actinin 2 #1, was shown to bind directly to
vaginal epithelial cells. These data suggest that α-actinin 2 is one of the virulence factors
responsible for the pathogenesis of T. vaginalis by serving as an adhesin to the host cells.
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host cells has been observed by fluorescence microscopy
[12]. Studies using erythrocytes as target cells demonstrated
that hemolysis by T. vaginalis is mediated by perforins and
the cytoskeleton [13]. Iron-regulated surface proteins of
T. vaginalis (AP65, AP51, AP33, and AP23) have been
postulated to play essential roles in the adherence of
T. vaginalis to VECs [3]. Interestingly, a mutant T. vaginalis
lacking its lipoglycan, TvLG, indicated that this surface
molecule also plays a role in attachment of the parasite to
host epithelial cells via specific interactions with galectin-1
of the host cell [14]. An evaluation of the adherence and
cytotoxicity of 26 T. vaginalis strains to prostate and
ectocervical epithelia, as well as erythrocytes, demonstrated
variable pathogenicity among different T. vagnialis strains,
but all strains showed contact-dependent cytolysis [15].
Among the immunogenic proteins of T. vaginalis identified
in the previous investigation [16], T. vaginalis α-actinin 2
(Tvα-actinin 2) had further been studied, showing its
ability to modulate host immune responses, using mouse
dendritic cells as well as human vaginal and prostate
epithelial cells [17]. Higher serological responses against
Tvα-actinin 2 in prostate cancer cases compared with the
control cases indicated a relationship between anti-
T. vaginalis seropositivity and risk for prostate cancer in
men [18, 19]. Reactive epitopes of α-actinin 2 have been
finely mapped using sera from both male and female
trichomoniasis patients [20]. Using a custom spot membrane
loaded with overlapped 11-mer peptides covering Tvα-
actinin 2, 13 epitopes were found to be scattered in α-actinin
2 when tested against women’s sera, whereas only 4 of the
15 epitopes in the C-terminal portion of α-actinin 2 were
reactive to men’s sera. 
In this study, the role of Tvα-actinin 2 in parasite adherence
to the prostate cell line RWPE-1 and to VECs was examined
by direct binding assays, and the domain of Tvα-actinin 2
responsible for cytoadherence was also defined.
Materials and Methods
Parasite and In Vitro Transformation
T. vaginalis KT4 [21] was grown in Diamond’s Trypticase Yeast
extract Maltose (TYM) medium [22] with 10% horse serum (Gibco
BRL, Germany) at 37ºC in 5% CO
2
, and transferred into fresh
medium daily. T. vaginalis trophozoites were converted into the
amoeboid form by incubating them in fibronectin-coated plates
(3 μg/ml) for 30 min.
Bacterial and Human Cell Cultures
Plasmids used for molecular manipulations are listed in
Table 1. Escherichia coli BL21 (DE3) cells were grown at 37ºC in
Luria-Bertani medium (0.5% yeast extract, 1% tryptone, 1% NaCl,
pH 7.5) supplemented with 100 μg/ml ampicillin (Sigma-Aldrich,
USA) in order to maintain the plasmids. Medium components
were obtained from BD-Difco (USA).
Human VECs (ATCC CRL-2614; American Type Culture
Collection, USA) were cultivated in Dulbecco’s modified Eagle’s
medium (DMEM; Gibco BRL) supplemented with 10% heat-
inactivated fetal bovine serum (FBS), penicillin (100 U/ml), and
streptomycin (100 μg/ml). Human prostatic epithelial cells
(RWPE-1, ATCC CRL-11609; American Type Culture Collection)
were grown using Keratinocyte Serum Free Medium (K-SFM;
Gibco BRL) containing epidermal growth factor (0.2 ng/ml), bovine
pituitary extract (0.05 mg/ml), FBS (5%), penicillin (100 U/ml),
and streptomycin (100 μg/ml). These human epithelial cells were
Table 1. Primers and plasmids used in this study. 
Name Relevant characteristicsa Source
Primers
α-actinin2-1F CGGAATTCGATGTCTGTTCGTCGTGAAGG (EcoRI)
α-actinin2-1R CGGCTCGAGTGCGAAAGCCTTCTCGCAGGCG (XhoI)
α-actinin2-2F ACGCGTCGACGCTTGCAAGGAACTCGGCAT (SalI)
α-actinin2-2R TTTTTTGCGGCCGCCTTGTAGTTGAGCTTGAATT (NotI)
α-actinin2-3F ACGCGTCGACGTCACATACACATACTCTGA (SalI)
α-actinin2-3R TTTTTTGCGGCCGCTTGGTTGTAAAGTGAGT (NotI)
Plasmids
pET21b Expression vector for a histidine-tagged protein Novagen
pETα-actinin2 pET21b, 2,786-bp α-actinin 2 gene [30]
pETact1 pET21b, 591-bp N-terminal portion of α-actinin 2 gene This study
pETact2 pET21b, 1,358-bp central portion of -actinin 2 gene This study
pETact3 pET21b, 843-bp C-terminal portion of α-actinin 2 gene This study
aUnderlined sequences indicate restriction sites.
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cultured to 80-90% confluence for use in the adhesion and
cytotoxicity assays at 37ºC/5% CO
2
.
Expression and Purification of Recombinant Tvα-Actinin 2
Polypeptides
The DNA fragment encoding Tvα-actinin 2 was divided into
three portions (Fig. 1). The 5’-region of the Tvα-actinin 2 gene
(591 bp) was made from the genome of T. vaginalis KT4 by PCR
using the primers α-actinin2-1F and α-actinin2-1R (Table 1), and the
central region of the Tvα-actinin 2 gene (1,358 bp) was amplified
with another set of primers, α-actinin2-2F and α-actinin2-2R. The
3’-region of the Tvα-actinin 2 gene was amplified as an 843-bp
DNA fragment, using the primers α-actinin2-3F and α-actinin2-3R.
Each of the resulting Tvα-actinin 2 DNA fragments was cloned
into pET21b (Novagen, Germany), yielding overexpression
plasmids for the truncated α-actinin 2 proteins (pETact1, pETact2,
and pETact3). 
These truncated Tvα-actinin 2 proteins were expressed as
histidine-tagged form in E. coli BL21 (DE3) with 1 mM isopropyl
β-D-thiogalactoside, and then purified using nickel-nitrilotriacetic
acid affinity chromatography as described by the manufacturer
(Qiagen, Germany). Full-length recombinant Tvα-actinin 2 (rTvα-
actinin 2) was prepared as previously described [17].
Western Blot Analysis
These rTvα-actinin 2 polypeptides (100 ng) were subjected to
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE), and then transferred to a nitrocellulose filter (Millipore,
USA). The membrane was incubated with pooled sera (1:200
dilution) derived from trichomoniasis patients in a blocking
solution (Tris-buffered saline (TBS; 50 mM Tris-Cl and 150 mM
NaCl, pH 7.5), 5% skim milk, and 0.05% Tween 20), and incubated
with alkaline phosphatase (AP)-conjugated anti-human IgG
(Sigma-Aldrich). As a control, these proteins were also reacted
with normal sera (1:200 dilution) derived from uninfected
individuals. The immunoreactive protein was visualized using
the nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate
system (Promega, USA).
Immunofluorescence Assays (IFA)
Trophozoites and amoeboid forms of T. vaginalis were adhered
to glass slides, and then incubated with 100% methanol at -20ºC
for 10 min. After 1 h incubation in a blocking buffer (phosphate-
buffered saline (PBS: 1.7 mM KCl, 137 mM NaCl, 2 mM KH
2
PO
4
,
and 10 mM Na
2
HPO
4
, pH 7.3), 5% goat serum, and 3% bovine
serum albumin (BSA)), the cells were reacted with anti-Tvα-
actinin 2 polyclonal antibodies (1:800 dilution) [17] at 4°C.
Following three washes with PBS, the cells were reacted with
Alexa-Fluora 555-conjugated anti-rat IgG (1:400 dilution; Life
Technologies, USA) at 37°C for 2 h. The slides were washed with
PBS and mounted with 1.5 μg/ml 4’6-diamidino-2-phenylindole
(DAPI; Sigma-Aldrich) anti-fade mounting medium (VECTASHIELD;
Vector Laboratories, USA). The cells were then observed under an
Axiovert 200 fluorescent microscope or LSM710 confocal microscopy
(Carl Zeiss, Germany). 
Protein Fractionation from Amoeboid Form of T. vaginalis
Cytoplasmic and membrane fractions of the T. vaginalis were
prepared using the subcellular Proteome Extraction Kit (Merck,
Germany). One microgram of protein samples was separated by
10% SDS-PAGE and transferred to polyvinylidene difluoride
(PVDF) membranes and blocked with the blocking solution for 1 h
at room temperature. The membranes were treated with anti-Tvα-
actinin 2 antibodies at 4ºC overnight, and reacted with horseradish
peroxidase (HRP)-conjugated secondary antibodies (Cell Signaling,
USA). An Enhanced Chemiluminescence System (ECL; GE
Healthcare Life Science, UK) was used for signal detection.
Labeling of T. vaginalis and Blocking Experiments
T. vaginalis cells were stained with the fluorescent Cell Tracker
Orange CMTMR dye (Invitrogen, USA). Briefly, T. vaginalis cells
(1 × 106 cells/ml) were incubated in pre-warmed cell tracker dye
solution (0.5 μM in TYM medium without serum) for 30 min at
37ºC. The cells were harvested by centrifugation, and then
incubated in TYM medium supplemented with 10% FBS at 37ºC
for 30 min. The parasites were then washed twice: once with TYM
medium and once with complete K-SFM.
Fig. 1. rTvα-actinin 2 protein of T. vaginalis and its truncated derivatives used in this study. 
Four different rTvα-actinin 2 polypeptides were prepared containing the complete Tvα-actinin 2 open reading frame (rTvα-actinin 2), and the N-
terminal (rTvα-actinin 2 #1), central (rTvα-actinin 2 #2), and C-terminal (rTvα-actinin 2 #3) regions. The three boxes above these numbers
represent the actin-binding domain, central antigenic region, and Ca2+-binding domain of Tvα-actinin 2 (Addis et al. [25]).
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Prior to cytoadherence assays, T. vaginalis trophozoites (1 × 108)
were pre-incubated with anti-Tvα-actinin 2 antibodies for 1 h at a
concentration of 30 μg/ml. As a control, pre-immune rat serum
was used to monitor the nonspecific effect of serum on the
cytoadherence of T. vaginalis to the host cells.
Cytotoxicity Assays and Blocking Experiments 
VECs (3 × 104 cells/well) inoculated into 96-well plates were
cultured to confluence at 37ºC/5% CO
2
. T. vaginalis cells (3 × 105
cells/well) at log phase were added to the confluent VECs, and
then incubated for 4 h at 37ºC/5% CO
2
. Lysis of VECs was
measured by determining the level of released lactate dehydrogenase
(LDH) using the Cytotox96 Non-Radioactive Cytotoxicity Kit
(Promega). The level of released LDH was determined as follows:
[(OD
490
 of experimental LDH – OD
490
 of spontaneous LDH)/(OD
490
of maximum LDH – OD
490
 of spontaneous LDH)] × 100. The
spontaneous LDH was the activity of LDH released from untreated
VECs, whereas the maximum LDH was the LDH activity caused
from complete lysis of VECs due to Triton X-100 treatment.
To examine the role of Tvα-actinin 2 in cytotoxicity of T. vaginalis
to VECs, T. vaginalis trophozoites (1 × 108) were pre-incubated
with anti-Tvα-actinin 2 antibodies for 1 h at a concentration of
30 μg/ml. In order to monitor the nonspecific effect of serum on
the cytotoxicity of T. vaginalis to VECs, pre-immune rat serum was
used as a control. 
Labeling of rTvα-Actinin 2
To estimate the binding of rTvα-actinin 2 to the host cells, Tvα-
actinin 2 proteins were labeled with a fluorescent probe using an
Alexa-Fluor 555 Microscale Protein Labeling Kit (A30007; Molecular
Probes, USA). One hundred microgram of recombinant polypeptides
was reacted with Alexa-Fluor 555 succinimidyl ester, and then
passed through the spin-filters supplied with the kit to remove
unincorporated probe. Fluorescence of the proteins was measured at
280 and 555 nm in order to check labeling of the protein as directed
by the manufacturer. Alexa-Fluor 555-labeled α-actinin 2 (100 μg/ml)
was stored at -20ºC before being used for the binding assays.
Fluorescence-Activated Cell Sorter (FACS) Analysis
FACS analysis was carried out by using a BD FACS Calibur
flow cytometer (BD Biosciences, USA). For the adhesion assay,
Cell Tracker Orange CMTMR-stained T. vaginalis can be detected
in excitation and emission spectrum peak wavelengths of
approximately 488 and 565 nm. Additionally, Alexa-fluor 555-
labeled proteins have fluorescence excitation and emission
maxima of 555 and 565 nm. To detect CMTMR-stained parasites
or Alexa-fluor 555 dye-labeled proteins in the presence of VECs or
RWPE-1, voltage sets were made based on the auto-fluorescent
signal of the VECs and RWPE-1. Finally, FACS data analyses were
performed using FlowJo software (FlowJo LLC, USA).
Fluorescence Microscopy
rTvα-actinin 2 proteins were conjugated with a fluorescent
probe using an Alexa-Fluor 555 Microscale Protein Labeling Kit as
described above. VEC cells (2 × 104 cells per well) were grown on
glass coverslips in 24-well plates for 24 h. The cells were
incubated with 3% BSA for 30 min in DMEM without serum
followed by a 1 h treatment with 10 μg/ml Alexa-Fluor 555-labeled
polypeptides at 37ºC, and then fixed in 3.7% paraformaldehyde/
PBS at room temperature for 30 min. After being washed with PBS
three times, the cells were observed under an Axiovert 200
fluorescence microscope. 
Ligand-Binding Immunoblotting Assay
Each well of a 24-well culture plate was seeded with VECs (2 ×
105), and incubated overnight at 37ºC in the presence of 5% CO
2
.
After removing the medium and washing twice with DMEM, the
cells were incubated in 1 ml of serum-free DMEM containing
10 μg of the rTvα-actinin 2 proteins as previously described [23].
After five washes with DMEM, the cells were disrupted with
150 μl of lysis buffer (10 mM Tris-HCl, pH 8.4, and 0.8 % SDS) and
boiled for 10 min. To examine whether rTvα-actinin 2 was stably
bound to VEC monolayers, a portion of the lysate (15 μg of protein)
was subjected to SDS-PAGE and then transferred onto a PVDF
membrane. The membranes were blocked with 5% non-fat dry milk
in TBS with 0.05% Tween 20 for 1 h at room temperature, treated with
anti-Tvα-actinin 2 antibodies at 4ºC overnight, and subsequently
reacted with AP-conjugated anti-rat IgG (Sigma-Aldrich).
In the case of truncated rTvα-actinin 2 proteins, #1, #2, and #3,
the membranes were treated with anti-histidine Abs (IG Therapy,
Korea) instead of anti-rTvα-actinin 2 antibodies. They were then
incubated with HRP-conjugated secondary antibodies (Cell
Signaling), and the immunoreactive bands were visualized using
an ECL System (GE Healthcare Life Science). To monitor the
protein level of VECs in each treatment, the VEC lysates were
monitored for their β-actin levels using anti-human β-actin
antibodies (Millipore).
Statistical Analyses
Results are indicated as the means ± standard deviations obtained
from three independent experiments. Data were analyzed by pair-
wise comparison using the Student’s t-test (SYSTAT program,
SigmaPlot ver. 10; Systat Software Inc., USA). Differences were
considered statistically meaningful if the p-values were <0.05.
Results
Reactivity of Recombinant Tvα-Actinin 2 Proteins against
Patients’ Sera
T. vaginalis α-actinin 2 was previously identified as one
of the immunogens recognized by sera of T. vaginalis-
infected women [24]. Full-length rTvα-actinin 2 protein
was expressed in E. coli and purified via Ni2+-NTA affinity
chromatography. ELISA was performed with 10 female
patients’ sera (data not shown). Nine of 10 sera were reactive
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to this recombinant protein. In the subsequent experiment,
a pool of nine sera was used for immunopositive sera, and
the human serum showing no reactivity to rTvα-actinin 2
served as a negative control (Fig. 2). 
Analysis of the deduced amino acid sequence of Tvα-
actinin 2 revealed that this protein is composed of an
N-terminal actin-binding domain, a central domain rich in
α-helices, and a C-terminal region with Ca2+-binding
activity [25]. Three truncated recombinant Tvα-actinin 2
proteins were prepared (Fig. 2A) and used to define the
protein regions reactive to patients’ sera. Western blot
analysis of these partial rTvα–actinin 2 proteins with the
pooled patients’ sera indicated that the central (#2) and
C-terminal portions (#3), but not the N-terminal part (#1) of
Tvα-actinin 2, reacted with patients’ sera (Fig. 2B). In
contrast, these proteins did not show any reactivity with
the pre-immune serum used as a negative control (Fig. 2C).
Localization of Tvα-Actinin 2 in T. vaginalis
Using antibodies specific to rTvα-actinin 2, IFAs were
performed to examine the intracellular location of Tvα-
actinin 2 in two different forms of T. vaginalis, trophozoites
and amoebic form (Figs. 3A and 3B/3C, respectively). Tvα-
actinin 2 was mainly detected in the cytoplasm of T. vaginalis
trophozoites. A conformational change into the amoeboid
form occurred upon contact of T. vaginalis trophozoites with
fibronectin. Interestingly, the amoebic form of T. vaginalis
showed localization of Tvα-actinin 2 near the plasma
membranes. Observation of the amoebic T. vaginalis at
higher magnification indicated that Tvα-actinin 2 also
locates near the membranes. 
In the subsequent experiment, fibronectin-induced amoebic
T. vaginalis cells were fractionated into cytoplasmic,
membrane, and secreted proteins, and then analyzed by
western blot analysis using anti-Tvα-actinin 2 antibodies
(Fig. 3D). Interestingly, this protein was found in all the
three fractions of T. vaginalis, indicating that Tvα-actinin 2
is secreted or present at the surface of T. vaginalis.
Additional IFAs were performed to observe the location
of Tvα-actinin 2 when T. vaginalis was incubated with
VECs or RWPE-1 (Figs. 3E and 3F, respectively). Most
T. vaginalis cells were in the amoeboid form upon incubation
with both the vaginal and prostate epithelial cell lines and,
under these conditions, IFAs of T. vaginalis with anti-rTvα-
actinin 2 antibodies showed localization of Tvα-actinin 2
near its plasma membrane. 
Binding of T. vaginalis to VEC and RWPE-1 Cells
The ability of the pathogenic trichomonads to adhere to
Fig. 2. Reactivity of rTvα-actinin 2 polypeptides to a pool of
immunopositive sera. 
(A) A silver-stained SDS-PAGE gel of rTvα-actinin 2 proteins. (B)
Western blot analysis of these Tvα-actinin 2 proteins with sera
derived from patients with trichomoniasis. (C) Western blot analysis
of these Tvα-actinin 2 proteins with a negative control serum
showing no reactivity to rTvα-actinin 2 by ELISA. Lane1: protein size
marker; lane 2: full-length rTvα-actinin 2; lane 3: rTvα-actinin 2 #1;
lane 4: rTvα-actinin 2 #2; lane 5: rTvα-actinin 2 #3.
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host cells is required for its survival and a prerequisite to
host cell killing [26]. Here, adherence of T. vaginalis to VEC
or RWPE-1 was quantified by flow cytometry analysis
using fluorescence-labeled T. vaginalis (Figs. 4A and 4B for
VEC; Fig. 4C for RWPE-1). 
An experiment was then performed to examine whether
masking of Tvα-actinin 2 on the T. vaginalis surface inhibited
the parasites’ adherence to these cells (Fig. 4B for VEC;
Fig. 4C for RWPE-1). For both cell lines, a significant
decrease in cytoadherence of T. vaginalis was observed
upon pretreatment with anti-Tvα-actinin 2 antibodies. As a
control, T. vaginalis incubated with pre-immune serum was
used for the adherence tests, and no effect on VEC or
RWPE-1 binding ability was observed. 
Role of Tvα-Actinin 2 in Cytotoxicity of T. vaginalis to VECs
We examined whether incubation of T. vaginalis with
anti-Tvα-actinin 2 antibodies affected the pathogen’s ability
to kill VECs. After VECs were incubated with T. vaginalis or
T. vaginalis pretreated with anti-Tvα-actinin 2 antibodies,
the viability of the VECs was monitored by measuring the
released LDH (Fig. 4D). VECs treated with T. vaginalis at a
multiplicity of infection of 10 for 4 h demonstrated 82%
LDH release relative to the LDH of the total cells used in
the assays. The cytotoxicity of T. vaginalis pretreated with
anti-Tvα-actinin 2 antibodies was decreased to 59% in
contrast with 80% cytotoxicity of pre-immune serum-
treated T. vaginalis. 
Binding of Tvα-Actinin 2 to VECs and RWPE-1 Cell Lines
We then investigated whether Tvα-actinin 2 binds directly
to host cells, by (i) flow cytometry analysis, (ii) observation
of the cell lines incubated with fluorescence-labeled rTvα-
actinin 2 proteins, and (iii) ligand immunoblotting binding
assays. 
After VEC and RWPE-1 cells were incubated with
Fig. 3. Localization of Tvα-actinin 2 in T. vaginalis. 
Using rTvα-actinin 2 antibodies, the localization of Tvα-actinin 2 was examined in T. vaginalis trophozoites (A), amoeboid forms (B, C), T. vaginalis
incubated with vaginal epithelial cells (VECs) (E), and T. vaginalis incubated with prostate cells (RWPE-1) (F). The scale bars represent 5 μm. (D) T.
vaginalis exposed to fibronectin was used for the fractionation experiments into cytoplasmic, membrane, and secreted proteins. The protein
fractions were analyzed by western blot assay using anti-Tvα-actinin 2 antibodies.
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fluorescence-labeled rTvα-actinin 2, they were analyzed by
FACS (Fig. 5A). Significant portions of the cell lines (65%
and 51%) were labeled with fluorescent proteins in the case
of VEC and RWPE-1, respectively. Binding of labeled rTvα-
actinin 2 was also observed with a fluorescence microscope,
as shown in Fig. 5B. 
In addition, VECs were incubated with rTvα-actinin 2,
and cell lysates were prepared for use in the western blot
analysis with anti-rTvα-actinin 2 antibodies (Fig. 5C(a)).
The lysates prepared from the VECs incubated with rTvα-
actinin 2 indicated that rTvα-actinin 2 binds to VECs
(lane 3). As a loading control, the amount of human β-actin
in the VEC lysates was also monitored (Fig. 5C(b)). A
similar level of human β-actin was observed in each lysate
sample, indicating that the absence of rTvα-actinin 2 in
lane 2 of Fig. 5C(a) was not caused from a lower level of
protein of human cell lysates loaded into the same lane. 
Determination of the Binding Domain of Tvα-Actinin 2
to Cell Lines
Additional experiments were performed to define the
domain of rTvα-actinin 2 involved in the adherence of
Fig. 4. Role of Tvα-actinin 2 in T. vaginalis cytoadherence and cytotoxicity to vaginal epithelial cells (VECs) and prostate epithelial
(RWPE1) cells. 
(A) A histogram showing the binding of fluorescence-labeled T. vaginalis to VECs determined by flow cytometric analysis. T. vaginalis was stained
with 0.5 μM CMTMR to determine staining intensity compared with unstained T. vaginalis. Stained trichomonads were incubated with VECs at an
MOI of 10 for 6 h and washed in free growth medium five times to discriminate unbound cells. (B, C) Bar graphs that show average adherence of
CMTMR-stained T. vaginalis or CMTMR-stained T. vaginalis with VECs (B) and RWPE-1 (C) pretreated with anti-Tvα-actinin 2 antibodies for 1 h at
a concentration of 30 μg/ml. Pre-immune rat serum was used as a control to monitor the nonspecific effect of serum on the binding of T. vaginalis
to VECs. (D) Role of Tvα-actinin 2 in cytotoxicity of T. vaginalis to VECs. T. vaginalis trophozoites were pre-incubated with anti-Tvα-actinin 2
antibodies for 1 h at a concentration of 30 μg/ml. Pre-immune rat serum was used as a control to monitor the nonspecific effect of serum on the
cytotoxicity of T. vaginalis to VECs. Statistical analyses for pair-wise comparisons were performed using Student’s t-tests to evaluate the statistical
significance of these results. Differences with p < 0.05 were considered significant. **p < 0.001.
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rTvα-actinin 2 to VECs (Fig. 6). The deduced amino acid
sequence of Tvα-actinin 2 revealed that this protein is
composed of an N-terminal actin-binding domain, a central
domain rich in α-helices, and a C-terminal region with
Ca2+-binding activity [24]. Tvα-actinin 2 protein was
separated into three parts as histidine-tagged forms (Fig. 1).
Truncated rTvα-actinin 2 proteins were determined for
their cytoadherence to VECs by flow cytometry analysis
(Fig. 6A). Compared with VECs without labeled protein
(5.8%), all three truncated and labeled Tvα-actinin 2 proteins
demonstrated significant binding to VECs (23~87%).
Among them, Tvα-actinin 2 #1, containing the N-terminal
domain of the protein, showed the highest binding ability.
Binding of these three truncated rTvα-actinin 2 proteins to
VECs was observed using a fluorescence microscope
(Fig. 6B). rTvα-actinin 2 proteins were tagged with red
fluorescent Alexa-Fluor 555, and then added to VECs. Only
the VECs treated with rTvα-actinin 2 #1 demonstrated red
fluorescence, whereas VECs incubated with rTvα-actinin 2
#2 or #3 showed no fluorescence signal. 
Fig. 5. Binding of rTvα-actinin 2 protein to the cell lines. 
(A) Flow cytometric analysis of rTvα-actinin 2 binding to vaginal epithelial cells (VECs) and prostate epithelial (RWPE1) cells. A histogram
showing the binding of fluorescence-labeled α-actinin 2 of T. vaginalis to cell lines determined by FACs. As a control, VECs were incubated with
unlabeled rTvα-actinin 2 and analyzed. (B) Labeled rTvα-actinin 2 protein binding to VECs. (a) VECs incubated with labeled rTvα-actinin 2 (red)
merged with DAPI (blue); (b) VECs incubated with labeled rTvα-actinin 2 (red); (c) VECs incubated with labeled rTvα-actinin 2 under differential
interference contrast. The bars represent 20 μm. (C) Ligand-binding immunoblotting assays. VECs (2 × 105) were incubated with 10 μg of the rTvα-
actinin 2 proteins. After five washes, the cells were lysed, and analyzed by western blot assay using anti-Tvα-actinin 2 antibodies. The same VEC
lysates were analyzed for their β-actin content as a loading control by western blot assay. Lane 1: protein size marker; lane 2: VECs alone; lane 3:
VECs with rTvα-actinin 2; lane 4: rTvα-actinin 2 (5 ng). 
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Fig. 6. Determination of the Tvα-actinin 2 domain that binds to vaginal epithelial cells (VECs). 
(A) Flow cytometric analysis of the truncated rTvα-actinin 2 protein binding to VECs. (B) Binding of the truncated rTvα-actinin 2 proteins to
VECs. VECs with labeled, truncated rTvα-actinin 2 (red) merged with DAPI (blue) are presented on the left side and VECs under differential
interference contrast are presented on the right side. The bars represent 20 μm. (C) Ligand-binding immunoblotting assays. VECs (2 × 105) were
incubated with 10 μg of one of the three truncated rTvα-actinin 2 proteins, #1, #2, and #3. After five washes, the cells were lysed, and analyzed by
western blot assay using anti-histidine antibodies. The same VEC lysates were analyzed for their β-actin content as a loading control by western
blot assay. Lane 1: VECs alone; lane 2: VECs with rTvα-actinin 2 #1; lane 3: VECs with rTvα-actinin 2 #2; lane 4: VECs with rTvα-actinin 2 #3; lanes
5-7: rTvα-actinin 2 #1-#3 reacted with anti-histidine antibodies (5 ng each).
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These truncated rTvα-actinin 2 proteins were also used
for ligand immunoblotting binding assays using anti-
histidine antibodies (Fig. 6C). Only the rTvα-actinin 2 #1
protein, containing the actin-binding domain, was detected
in VEC lysates (lane 2). On the other hand, the other two
rTvα-actinin 2 proteins, #2 and #3, were not observed in
VEC lysates (lanes 3 and 4, respectively). Western blot
analysis of human β-actin in the VEC lysates indicated that
similar amounts of proteins were used in the assay. These
results demonstrated that rTvα-actinin 2 binds directly to
VECs via its N-terminal region.
Discussion
After being identified as an immunogenic protein
reacting to anti-T. vaginalis IgGs of female patients with
trichomoniasis [24], Tvα-actinin 2 has even been used to
monitor men’s serological samples for trichomoniasis
exposure and risk of prostate cancer [19]. To be functional
in the host interaction, this protein in the pathogen should
be secreted or be present on its outermost surface. In this
study, T. vaginalis was transformed in vitro into the
amoeboid form, and Tvα-actinin 2 was also observed near
the membranes of the amoeboid form (Figs. 3B and 3C).
Conversion of T. vaginalis into the amoebic form and the
concurrent membrane localization of Tvα-actinin 2 were
observed upon incubation with VECs and RWPE-1 (Figs. 3E
and 3F, respectively). Fractionation experiments indicated
that Tvα-actinin 2 was located in the plasma membranes
and secreted from T. vaginalis (Fig. 3D).
Incubation of T. vaginalis with VECs induced the
expression of certain T. vaginalis genes, including AP-65,
AP-33, and Tvα-actinin 2 [27]. This is in agreement with the
study of Addis et al. [25], in which the expression of Tvα-
actinin 2 increased in the amoebic form of T. vaginalis. The
membrane localization and induced expression of Tvα-
actinin 2 in the amoebic form of T. vaginalis suggest its role
in cytoadherence of T. vaginalis to the host cells, which may
trigger an immune response or lead to death of the host
cells. The role of Tvα-actinin 2 as an immunomodulator has
already been demonstrated using human epithelial cell
lines and mouse dendritic cells challenged with rTvα-
actinin 2 [17]. In this study, an additional role of Tvα-
actinin 2 as an adhesin was shown by the decreased
number of T. vaginalis that adhered to VECs and RWPE-1
in the antibody-blocking experiment (Figs. 4B and 4C,
respectively). Treatment with Tvα-actinin 2-specific antibodies
resulted in the attenuated cytotoxicity to VECs (Fig. 4D),
caused from the decreased binding of antibody-treated
T. vaginalis. Among the identified adhesins, Tvα-actinin 2 is
the trichomonad’s molecule showing immunomodulating
activity.
Owing to the actin-binding domain at its N-terminus, this
protein was identified as an actinin [28]. Direct interaction
of Tvα-actinin 2 with actin was observed by actin-binding
assays using polymerized actin (Lee and Park, unpublished
results). Thus, it is likely that Tvα-actinin 2 becomes
important under specific stages of T. vaginalis (i.e., upon
exposure to the host cells via direct interaction with actin).
A search of the T. vaginalis genome demonstrated that five
Tvα-actinin genes encode an N-terminal actin-binding
domain, a C-terminal Ca2+-binding domain, and a central
variable domain [29]. Among these genes, Tvα-actinin 3
was identified to bind the iron-responsible element of
Tvcp4 RNA encoding T. vaginalis cysteine proteinase 4, thus
participating in post-transcriptional iron regulation. The
various roles and expression of these genes should be
examined. 
It is possible that Tvα-actinin 2 in the amoeboid form of
T. vaginalis binds to the host epithelial cells via direct
association with surface component(s) of the host cells.
This study showed a direct binding of rTvα-actinin 2 protein
to the epithelial cells via flow cytometry measurement
(Fig. 5A), fluorescence microscopy using the labeled Tvα-
actinin 2 proteins (Fig. 5B), and ligand immunoblotting
assays (Fig. 5C). Experiments using the truncated Tvα-
actinin 2 clearly demonstrated that the N-terminal actin-
binding domain of Tvα-actinin 2 plays a role in host
adherence (Fig. 6). 
These data indicate that Tvα-actinin 2 plays a role in the
pathogenesis of T. vaginalis by serving as one of the
adhesins to the host cells. The N-terminal domain containing
a putative actin-binding sequence was important for its
adhesion to the host epithelial cells. 
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